Resolid CAT
COMBINED LIVE ATTENUATED VACCINE AGAINST RHINOTRACHEITIS, CALICIVIROSIS AND PANLEUKOPENIA
COMBINED LIVE ATTENUATED VACCINE AGAINST RHINOTRACHEITIS, CALICIVIROSIS AND PANLEUKOPENIA
Resolid Cat Prospectus
Resolid CAT
Pharmaceutical Formulation: Lyophılısate For Suspensıon For Injectıon
Cats.
COMPOSITION:
Each single dose of the vaccine contains the following components:
Lyophilised Suspension for Injection
| Active ingredients | Amount | Function |
| Attenuated Feline calicivirus strain F9 | ≥104,6 TCID 50/dose* | Immunising antigen |
| Attenuated Feline herpesvirus type 1 strain FVRm | ≥105,2 TCID 50/dose* | |
| Attenuated Feline panleukopenia virus strain Philips-Roxane | ≥104,0 FAID50/dose** | |
| Excipients | ||
| Lactalbumin hydrolysate | 0,25 mg/dose | Stabiliser |
| Sucrose | 0,50 mg/dose | |
* Tissue Culture Infective Dose
RESOLİD CAT is administered in cats for prophylactic purposes against viral rhinotracheitis caused by Feline herpesvirus type 1, calicivirosis caused by Feline calicivirus, and panleukopenia caused by Feline panleukopenia virus. Following the booster vaccination, an immune response is established after 4 weeks for Feline calicivirus and Feline herpesvirus type 1, and after 3 weeks for Feline panleukopenia virus. The duration of immunity is 1 year following vaccination.
The solvent is added to the lyophilised pellet. The vaccine is slowly reconstituted to obtain a homogeneous suspension with limited foam formation. After reconstitution, a clear, pink-coloured suspension for injection is obtained. The product is withdrawn into a syringe and administered by the subcutaneous route at a dose of 1 dose (1 ml) to kittens from 8 weeks of age and to adult cats. For protective immunity, vaccination is performed twice at an interval of 4 weeks. Vaccination should be repeated annually.
Lyophilised suspension for injection:
Store at 2–8 °C and protect from light. Do not freeze.
Shelf life: 24 months.
Diluent for parenteral administration:
Store below 25 °C, protected from light, without refrigeration. Do not freeze.
Shelf life: 24 months.
The reconstituted vaccine should be used within 2 hours.
Not for use in food-producing animals.
The vaccine is packaged in 2R Type I colourless glass vials containing a single-dose lyophilised pellet, and in 1 ml 2R Type I colourless glass vials containing the diluent for parenteral administration. The glass vials are sealed with bromobutyl stoppers and aluminium caps and are appropriately labelled.
The product is placed on the market in plastic trays or boxes containing 10 × 1 dose lyophilised pellets and 10 × 1 ml diluent for parenteral administration. Not all pack sizes may be marketed simultaneously.
